ALEM is your highly experienced partner in the installation, relocation, maintenance, repair and refurbishment of all types of amusement rides & water slides, cable cars, and ski lifts. ALEM and its teams are familiar with all major ride and slide manufacturers.
Al Barakah Dates – Foodlinks
Al Barakah Dates is a leading producer of Date ingredients made from 100% dates such as Date Paste, Date Syrup, Date Powder, Chopped Dates, Golden Date Syrup and Colorless liquid Date Sugar. Everything is manufactured in-house at our state of the art production facility. We’re a BRC Grade A certified second generation family business that aims to provide manufacturers with clean and simple date ingredients to sweeten and add into their finished products.
Al Bayader International
Al Bayader International is a global manufacturer, distributor and retailer of creative solutions in sustainable food packaging, and personal & home care products. With a dedicated team of around 1,000+ employees from 30 different nationalities serving 9,000 business customers and millions of consumers and the support of over 400 business partners, the company delivers unquestionable value to the global food and beverage industry. With an extensive product portfolio, housing 4,000+ products, Al Bayader International represents the backbone of the retail and foodservice sectors in the UAE and the GCC region. As part of its constant expansion efforts, Al Bayader International currently owns and operates three manufacturing complexes with an ever-increasing production capacity of +31,000 tons per annum. With 16 industrial and logistics locations and 5 retail shops, the Company leads several GCC markets with a substantial market share, while steadily increasing penetration into markets further afield, including Europe and Africa. A product range to be proud of Al Bayader’s products are segmented into the following broad categories: Disposable Tableware Disposable Containers Baking Molds and Sheets Bags & Wrapping Systems Cleaning & Hygiene Products Food Decorations items Foil & Film rolls Paper products Bottles & Jars Hygiene and Safety products Foodstuff and Beverages Outdoor Activities & Barbecue Accessories
AIQ
AIQ is a UAE-based technology company specializing in artificial intelligence solutions tailored for the energy sector, with a mission to accelerate digital transformation across the oil, gas, and broader energy value chain. AIQ developed the world’s first Agentic AI solution for energy, ENERGYai, which is in deployment phase across ADNOC’s Upstream operations. The company has also developed and deployed a suite of AI tools that are driving efficiency and unlocking value for customers in the energy sector, today. Find out more at aiqintelligence.ae/
Abu Dhabi Investment Office
About HELM: Abu Dhabi’s Life Sciences Cluster HELM, short for Health, Endurance, Longevity, and Medicine, is Abu Dhabi’s flagship life sciences and biotechnology ecosystem, purpose-built to accelerate discovery, development and deployment across the full healthcare value chain. Launched in April 2025 during Abu Dhabi Global Healthcare Week (ADGHW), HELM is the emirate’s long-term strategic commitment to building sovereign life sciences capability, attracting global partnerships and shaping the next era of health innovation from Abu Dhabi. The cluster is spearheaded through a joint effort by the Abu Dhabi Investment Office (ADIO), the Abu Dhabi Department of Economic Development (ADDED) and the Department of Health – Abu Dhabi (DoH). Together, these entities are positioning HELM as a next-generation platform for translational research, precision medicine, AI-integrated HealthTech and advanced biomanufacturing, anchored in an economic landscape known for its stability, ambition and ability to execute at speed. In line with Abu Dhabi’s economic transformation strategy, HELM is projected to contribute over AED 94 billion (approximately $25.5 billion) to GDP by 2045. It is expected to attract AED 42 billion (approximately $11.4 billion) in investment and generate more than 30,000 skilled jobs. But its mission goes beyond numbers. HELM aims to deliver global health impact by bridging the innovation gap between frontier science and real-world deployment, starting in Abu Dhabi and scaling outward. An end-to-end ecosystem for life sciences innovation HELM supports life sciences innovation at every stage, from early discovery through to late-stage trials, regulatory enablement, manufacturing and market access. Rather than functioning as a single research park or free zone, HELM operates as a distributed but integrated cluster that links the key actors of the healthcare ecosystem: researchers, clinicians, regulators, manufacturers, and investors. The cluster’s core areas of focus include: • Genomics and Precision Medicine: Abu Dhabi has launched one of the most comprehensive national genomics programmes in the world. HELM aims to leverage this strong foundation to advance personalised therapies and public health strategies, with applications across oncology, rare disease, chronic illnesses and more. • AI and Digital Health: From remote diagnostics and real-time disease surveillance to predictive analytics and AI-accelerated drug discovery, is fostering a new generation of HealthTech solutions at the intersection of data and biology. • Advanced Biomanufacturing: The cluster is building GMP-compliant manufacturing capacity for biologics, vaccines, biosimilars and novel therapies, filling a strategic role in the supply chain in a region with fast-growing demand. • Translational R&D: Through partnerships with academic institutions, clinical research centres and industry leaders, HELM is accelerating the movement of ideas from lab to commercialisation, streamlining regulatory pathways and facilitating licensing while ensuring robust IP protections. • Workforce and Talent Development: HELM is investing in a skills pipeline across STEM, clinical and industrial disciplines, working in partnership with leading universities to ensure that the talent base grows alongside the sector. By connecting each facet of the healthcare value chain, HELM reduces friction across the research and development cycle, making it easier for global healthcare firms to test, pilot, localise and scale transformative life science solutions. About the Abu Dhabi Investment Office (ADIO) As the government entity responsible for accelerating Abu Dhabi’s economic transformation and attracting and enabling investment in Abu Dhabi, ADIO plays a foundational role in the development and success of the HELM cluster. ADIO works as an active, long-term partner committed to co-creating economic clusters that deliver strategic value and global market relevance, working directly with companies to de-risk investment, support growth and align innovation with Abu Dhabi’s economic priorities. In the context of HELM, ADIO supports investors and innovators through: • Business Acceleration Support: ADIO provides bespoke support to high-impact companies that is focused on long-term value creation and sustainable partnership. • Regulatory Enablement: ADIO works closely with local authorities, including DoH, to facilitate licensing, fast-track approvals and provide clarity on market entry pathways. • Infrastructure Access: ADIO supports companies with facility setup, utilities provisioning, site selection and authorisation, aligned with operational needs. • Partnership Facilitation: ADIO connects global firms to hospitals, universities, suppliers, contract manufacturers, and research bodies, ensuring access to a collaborative ecosystem and shared infrastructure. • Long-Term Strategic Alignment: Beyond operational support, ADIO helps companies align with Abu Dhabi’s industrial and economic development goals, ensuring sustainable access to public sector entities, funding opportunities and regional collaborations. Why Abu Dhabi, and why now? HELM was launched at an inflection point for the global life sciences sector. While scientific discovery is advancing at unprecedented speed, structural barriers may slow the path from innovation to impact. Fragmented supply chains, overburdened regulatory systems and limited access to emerging markets all present material challenges for life sciences companies, particularly those seeking to scale globally. Abu Dhabi offers a different proposition. As one of the most stable, well-capitalised, and globally connected regions in the world, it provides an ideal launchpad for companies looking to expand their impact. Key advantages include: • Strategic Location: At the crossroads of Europe, Asia and Africa, Abu Dhabi offers seamless access to more than 80% of the world’s population within just an 8-hour flight radius. With world-class ports, airports and integrated logistics infrastructure, Abu Dhabi is a natural base for regional operations and global expansion. • Economic Stability and Regulatory Clarity: Abu Dhabi’s consistent legal and regulatory frameworks provide clarity for international investors and operators. In healthcare, the Department of Health – Abu Dhabi is known for its forward-leaning, science-driven approach to regulation, being the first in the region to develop an AI in healthcare policy. • Government-Backed Innovation: HELM is integrated into Abu Dhabi’s long-term development plans, backed by committed capital and aligned across the emirate’s network of government entities. This ensures that companies benefit from policy continuity and cross-sector coordination. • Collaborative Market Dynamics: Abu Dhabi’s healthcare system is structured to enable partnership between the public and private sectors, from clinical trials to procurement. The emirate’s commitment to value-based care and preventative health creates opportunities for innovative approaches to pressing challenges in the field. • Access to Diverse Populations: With over 200 nationalities represented in Abu Dhabi, and one of the largest national genome sequencing initiatives in the world, Abu Dhabi offers a rich setting for clinical research and AI training, enhancing the global applicability of solutions developed locally. Collaboration for global impact HELM is designed to be outward-facing, globally networked and fundamentally collaborative. It welcomes participation from US-based companies, research institutions, investors and healthcare providers seeking new opportunities for growth and high-impact platforms for deployment. Already, the cluster is attracting interest from multinational pharmaceutical companies, AI HealthTech firms and clinical research organizations. Through ADIO’s HELM cluster, US-based companies can explore: • Establishing regional HQs or R&D centres in Abu Dhabi • Partnering with Abu Dhabi-based universities on research For companies seeking new areas for commercialisation, partners for co-development or capital-efficient expansion, HELM provides a seamless platform to translate innovation into real-world outcomes. Connect with ADIO To explore opportunities within the HELM cluster or discuss how ADIO can support your company’s entry or expansion into Abu Dhabi, visit: HELM: https://www.helm.abudhabi ADIO: https://www.investinabudhabi.ae/en